Investigating the extracellular matrix in vascular development and maintenance

研究细胞外基质在血管发育和维持中的作用

基本信息

  • 批准号:
    8762215
  • 负责人:
  • 金额:
    $ 34.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-01 至 2018-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Intracerebral hemorrhages (ICH) and hemorrhagic stroke are a particularly fatal form of stroke and an important cause of long-term disability. This is especially true when they affect children and young adults. Effective treatments for hemorrhagic stroke are limited, and so ICH prevention is paramount for reducing the impact of this debilitating condition. However, preventative therapies often require an understanding of the pathogenic mechanism underlying ICH. Genetic studies have successfully defined the etiologies of some forms of ICH, however there is still a tremendous unmet need in determining the underlying causes of most forms of CVD. We have discovered that mutations in type IV collagen alpha 1 (COL4A1) cause a broad spectrum of highly penetrant cerebrovascular diseases (CVDs), including peri-natal stroke, congenital porencephaly, leukoencephalopathy, cerebral microbleeds, intracranial aneurysm, and ICH. In addition to multiple reports of COL4A1 mutations causing dominantly inherited CVD, our recent data suggest that 5-10% of patients suffering from sporadic ICHs have mutations in COL4A1 or its paralog COL4A2. Thus, according to American Heart Association estimates, mutations in COL4A1 and COL4A2 could cause up to 12,000 new cases of spontaneous ICH in the United States each year and 300,000 cases worldwide. Here we use novel genetic models of CVD to identify distinct roles for COL4A1 in vascular development and maintenance. Using genetic, molecular, and biochemical approaches we will directly test the regulation by COL4A1 of fundamental cell- signaling pathways that are critical for normal vascular development. Finally, we will use novel pre-clinical models of human CVD that we have generated to identify therapeutics that may be developed for use in patients and that may reduce their risk of suffering debilitating or fatal ICHs.
描述(由申请人提供):颅内出血(ICH)和出血性中风是一种特别致命的中风形式,也是导致长期残疾的重要原因。当它们影响到儿童和年轻人时尤其如此。出血性中风的有效治疗是有限的,因此预防脑出血对减少这种衰弱性疾病的影响至关重要。然而,预防性治疗通常需要了解脑出血的致病机制。遗传研究已经成功地确定了某些形式的脑出血的病因,然而,在确定大多数形式的心血管疾病的潜在原因方面,仍有巨大的未满足的需求。我们发现,IV型胶原α - 1 (COL4A1)突变可引起广谱的高渗透性脑血管疾病(cvd),包括围生卒中、先天性脑孔畸形、脑白质病、脑微出血、颅内动脉瘤和脑出血。除了多次报道COL4A1突变导致显性遗传性心血管疾病外,我们最近的数据表明,5-10%的散发性ICHs患者有COL4A1或其平行COL4A2突变。因此,根据美国心脏协会的估计,COL4A1和COL4A2的突变在美国每年可能导致多达12,000例自发性脑出血新病例,在全球范围内可能导致300,000例。在这里,我们使用新的CVD遗传模型来确定COL4A1在血管发育和维持中的不同作用。利用遗传、分子和生化方法,我们将直接测试COL4A1对正常血管发育至关重要的基本细胞信号通路的调节。最后,我们将使用新的临床前

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Douglas Gould其他文献

Douglas Gould的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Douglas Gould', 18)}}的其他基金

Gene therapy for disorders of the extracellular matrix
细胞外基质疾病的基因治疗
  • 批准号:
    10658481
  • 财政年份:
    2023
  • 资助金额:
    $ 34.56万
  • 项目类别:
Characterization of Tagged Type IV Collagen
标记的 IV 型胶原蛋白的表征
  • 批准号:
    10724541
  • 财政年份:
    2023
  • 资助金额:
    $ 34.56万
  • 项目类别:
2023 Collagen Gordon Research Conference and Seminar
2023年胶原蛋白戈登研究会议暨研讨会
  • 批准号:
    10675849
  • 财政年份:
    2023
  • 资助金额:
    $ 34.56万
  • 项目类别:
Role of the Unfolded Protein Response in Photoreceptor Degeneration
未折叠蛋白反应在光感受器变性中的作用
  • 批准号:
    10331719
  • 财政年份:
    2018
  • 资助金额:
    $ 34.56万
  • 项目类别:
Role of the Unfolded Protein Response in Photoreceptor Degeneration
未折叠蛋白反应在光感受器变性中的作用
  • 批准号:
    9927834
  • 财政年份:
    2018
  • 资助金额:
    $ 34.56万
  • 项目类别:
Role of the Unfolded Protein Response in Photoreceptor Degeneration
未折叠蛋白反应在光感受器变性中的作用
  • 批准号:
    10090604
  • 财政年份:
    2018
  • 资助金额:
    $ 34.56万
  • 项目类别:
Genetic and Mechanistic Study of Cerebral Small Vessel Disease
脑小血管病的遗传学及机制研究
  • 批准号:
    10213843
  • 财政年份:
    2017
  • 资助金额:
    $ 34.56万
  • 项目类别:
Genetic and Mechanistic Study of Cerebral Small Vessel Disease
脑小血管病的遗传学及机制研究
  • 批准号:
    9750841
  • 财政年份:
    2017
  • 资助金额:
    $ 34.56万
  • 项目类别:
Genetic and Mechanistic Study of Cerebral Small Vessel Disease
脑小血管病的遗传学及机制研究
  • 批准号:
    9979964
  • 财政年份:
    2017
  • 资助金额:
    $ 34.56万
  • 项目类别:
Investigating the extracellular matrix in vascular development and maintenance
研究细胞外基质在血管发育和维持中的作用
  • 批准号:
    9087349
  • 财政年份:
    2014
  • 资助金额:
    $ 34.56万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了